Posology: Adults: 0.5 ml.
Paediatric population: Children from 36 months onwards: 0.5 ml.
Children from 6 months to 35 months: Clinical data are limited.
Dosages of 0.25 ml or 0.5 ml may be given, for detailed instructions on
administering a 0.25 ml or 0.5 ml dose, see Special precautions for disposal and other handling under Cautions for Usage. The dose given should be in accordance with existing national recommendations.
For children, who have not previously been vaccinated, a second dose should be given after an interval of at least 4 weeks.
Children less than 6 months: the safety and efficacy of Influvac in children less than 6 months have not been established. No data are available.
Method of Administration: Immunisation should be carried out by intramuscular or deep subcutaneous injection. Precautions to be taken before handling or administrating the medicinal product: For instructions for preparation of the medicinal product before administration, see Special precautions for disposal and other handling under Cautions for Usage.